CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company ...
To reflect Venzee's new Jasper Business, Venzee proposes to change its name to "JasperX Technologies Inc." in the first quarter of 2026. Venzee's name change will be subject to acceptance by the TSXV ...
The closing of the private placement is expected to occur on or about January 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the ...
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and ...
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
The definitive agreement to acquire O'Connor was previously announced on May 28, 2025. "We are pleased to announce the successful first closing of the O'Connor transaction," said Bill Ferri, Head of ...
RBC Capital Markets served as exclusive financial advisor, KPMG served as accounting and tax advisor, and Sidley Austin served as legal advisor to Newfold.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
Copper Property CTL Pass Through Trust ("the Trust") has filed a Form 8-K containing its 2026 Annual Budget. The aggregate budgeted total expense amount stated in the Trust's 2026 Annual Budget is $15 ...
Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term ...
The venture loan and security agreement (the “Loan Agreement”) provides for a senior secured term loan facility in an aggregate principal amount of up to $30.0 million (collectively, the “Term Loans”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback